Affimed GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Heidelberg Germany (2000)

Organization Overview

First Clinical Trial
2010
NCT01221571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affimed GmbH | Affimed Inc. | Amphivena Therapeutics | Amphivena Therapeutics, Inc.